DLA Piper recently named Lisa LeCointe-Cephas as the new partner and chair of the life sciences sector in New York. This appointment sees LeCointe-Cephas, an established legal figure in the life sciences sector, bringing her expertise in managing crisis, compliance, litigation, and regulatory and enforcement challenges faced by pharmaceutical and medical device companies to DLA Piper. Her vast experience in these areas is projected to bolster the firm’s stature and efficiency in addressing intricate legal issues in the life sciences sector.
Prior to this, LeCointe-Cephas held a pivotal role in large-scale biopharmaceutical operations, upholding the position of a senior vice president and global chief ethics and compliance officer. Bloomberg Law provided an in-depth narration of this professional adjustment in a recent article.
In an ever-evolving legal landscape, her appointment demonstrates DLA Piper’s commitment to developing an unassailable life sciences representation and consultancy capacity in New York, which is one of the critical nerve centers of the global life sciences industry.
The shift of such a noteworthy figure highlights the dynamism and competitive spirits at play in law firms servicing life sciences and related sectors, intoning that they remain eager to attract top-notch talent to better serve their clientele.